Tissue Regenix Group plc

TRX.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents£1,075£1,870£3,461£4,650
Short-Term Investments£0£0£0£0
Receivables£4,115£4,380£4,582£3,028
Inventory£16,696£14,006£12,712£10,358
Other Curr. Assets£905£1,014£178£1,054
Total Curr. Assets£22,791£21,270£20,933£19,090
Property Plant & Equip (Net)£8,087£8,309£8,983£9,018
Goodwill£0£11,587£0£11,587
Intangibles£16,310£4,180£15,207£3,548
Long-Term Investments£0£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£0£0£0£0
Total NC Assets£24,397£24,076£24,190£24,153
Other Assets£0£0£0£0
Total Assets£47,188£45,346£45,123£43,243
Liabilities
Payables£6,845£2,714£4,569£1,207
Short-Term Debt£569£610£626£642
Tax Payable£261£636£0£345
Deferred Revenue£0£0£0£0
Other Curr. Liab.£239£2,195£400£2,541
Total Curr. Liab.£7,914£6,155£5,595£4,735
LT Debt£10,430£9,855£9,846£8,753
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£220£280£0£400
Other NC Liab.£0£0£340£0
Total NC Liab.£10,650£10,135£10,186£9,153
Other Liabilities£0£0£0£0
Cap. Leases£0£186£227£3,410
Total Liabilities£18,564£16,290£15,781£13,888
Equity
Pref Stock£0£0£0£29,470
Common Stock£92£92£92£91
Retained Earnings-£125,029-£124,095-£123,663-£123,764
AOCI£21,203£20,723£20,511-£529
Other Equity£133,099£133,099£133,099£132,996
Total Equity£29,365£29,819£30,039£30,150
Supplemental Information
Minority Interest-£741-£763-£697-£795
Total Liab. & Tot. Equity£47,188£45,346£45,123£43,243
Net Debt£9,924£8,595£7,011£4,745
Tissue Regenix Group plc (TRX.L) Financial Statements & Key Stats | AlphaPilot